Pharming (OTC:PHGUF) Stock, Quote.Headers.trade-ideas

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

News

Intraday Update

Markets

Movers

Trading Ideas

ACRFF

ADYEY

AGRO

ALFVY

AOSL

APAM

APTV

ATGN

AXSM

AYSI

BABA

BALMF

BAYK

BLAGF

BLBD

BNPQY

BXMT

CARO

CATN

CCOEY

CIVB

CLSD

CMRE

CNPRF

CPLP

CROX

CRSA

CRUS

CVNA

DEAC

DIOD

DRUNF

ECRO

EFBI

EPAC

Eaton Vance Tax-Advantaged Global Dividend

EURN

Eaton Vance Tax-Managed Global Diversified Equit

EXPGF

FFIN

FORM

FTNT

GBCI

GLPI

GMED

GZPFY

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HTHIF

HTHIY

HZNP

ICLR

IDEXF

IIJIY

IMKTA

INSW

IPXHY

IRWD

ISEE

ISSC

JSTTY

KDDIY

LARK

LBAI

LECO

LITE

Stocks That Hit 52-Week Highs On Thursday

Movers & Shakers

General

AACAY

AAPL

AAVXF

ACLLF

AHCHY

AIMT

ALCO

ALLE

AMTBB

ANGPY

APRE

APTO

ARCAY

ARES

ARGX

ARVN

ASPU

ASUUY

ATLKY

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BANF

BOCH

BOLD

BUKS

CBRE

CBSH

CCLAF

CDMO

CRSS

CSTM

CTBI

CUBA

DCPH

DEWY

DFCO

DPMLF

EDTXF

EFIN

EGRN

ENIA

ERRFY

ESLT

FELE

FLXN

FORTY

FSUGY

FTSV

GLDD

GOLF

GOSS

GSBD

GSGTF

HBAN

ICBK

IDEXY

IMMU

IMPUF

IMPUY

INCY

INSG

ITOCF

IVSXF

JADSF

JPRRF

KKKUF

KRMD

Stocks That Hit 52-Week Highs On Wednesday

ABLZF

ACNFF

AFGC

AGESY

AGPPF

ALBY

ARQL

ARRJF

ASCC

ATAZF

ATBYF

AUPH

BBIO

BCUCY

BCVVF

BKFKF

BRBR

BRMK

BSDGY

BYAGF

BYDIF

CGGYY

CGOOF

CHGCY

CMCXF

CODI

CSIOY

EBMT

EIDX

ESKYF

EXPR

FFBW

FMNB

Cohen & Steers Closed-End Opportunity Fund

FRRVY

FSBW

FSUMF

FXTGY

GBERY

GBNXF

GFED

GLPG

GMRE

CERRO DE PASCO RES INC by Cerro De Pasco Res Inc.

GPPRF

GSAH

Stocks That Hit 52-Week Highs On Tuesday

PHARMING GROUP NV ORD by Pharming Group NV

Pharming Group

Oppenheimer analyst Jeff Jones maintained a Buy rating on Pharming Group (PHAR – Research Report) today and set a price target of $31.00. The compa...

Oppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)

Pharming Group (PHGUF) has released an update. Pharming Group has initiated a Phase II clinical trial for leniolisib, targeting primary immunodefic...

Pharming Group Begins Leniolisib Phase II Trial

Pharming Group (PHGUF) has released an update. Pharming Group N.V. is set to release its third quarter financial results for 2024 on October 24, wi...

Pharming Group Announces Q3 2024 Financial Results

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Pharming Group (PHAR – Research Report) today and set a price target of $37.00....

Buy Rating Affirmed for Pharming Group on Leniolisib's Progress and Joenja's Market Expansion

Comments

Pharming

Pharming (PHGUF) Forecast

Pharming (OTC:PHGUF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga